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Abstract
Schistosomiasis (bilharzia) is a neglected parasitic disease caused by trematode flatworms of the genus Schistosoma which affects
over 240 million people worldwide. It is characterized by the formation of inflammatory granulomas around deposited parasite
eggs. Recent studies have revealed that immune and inflammatory responses play a crucial role in pathogenesis of schistosom-
iasis. The aim of this paper is to systematically evaluate the number and distribution of inflammatory cells in S. mansoni-infected
mice at different doses and time points. Immunohistochemistry was performed on lung and liver tissue sections from
Schistosoma-infected mice and uninfected healthy controls. Positively stained cells in whole-lung/liver tissue sections, surrounding
the eggs, and in the different compartments of the tissues, were counted. We found a significant increase in the number of mast
cells (toluidine blueþ), CD3þ cells, CD14þ cells, CD68þ cells, and CD15þ cells in Schistosoma-infected tissues compared with
untreated healthy controls (P 0.05 for all). Our findings revealed altered and enhanced immune cell infiltration in schistosom-
iasis. We suggest that these cells may contribute to the pathophysiology of Schistosoma resulting in pulmonary vascular
remodeling.
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Introduction
Schistosomiasis, also known as bilharzias, is a parasitic dis-
ease caused by trematodes which aﬀects more than 240 mil-
lion people worldwide. Humans become infected with
diﬀerent species of Schistosoma following exposure to
water contaminated by skin penetrating cercariae.1–4 The
immunological reaction of schistosomiasis (anti-egg
response) is probably the source of the pathogenesis and
pathophysiology that are orchestrated by granulomatous
inﬂammation.1–4 The response, in the mouse model, primar-
ily consists of proinﬂammatory cytokines and chemokines
(type-1 T-cell response) which later switches to type-2 T-cell
response. The T-cells, B-cells, antibodies, mast cells, macro-
phages, and dendritic cells as well as inﬂammatory cytokines
and chemokines are typical characteristics of this granu-
lomatous mesh.1–4 Although these reactions will help in
the destruction of eggs, it can induce other reactions such
as pulmonary vascular remodeling.
Taking advantage of the previous studies from our lab,5
we noticed that 92% of the lungs harvested from infected
mice contained evidence of granulomatous changes, second-
ary to egg deposition.5 Furthermore, in 46% of lungs we
witnessed vessel remodeling in close proximity to the granu-
loma and no remodeling was observed in the absence of
granulomas.5 Subsequent studies by the Schistosomiasis-
Pulmonary Vascular Research Institute (PVRI) taskforce
have summarized that inﬂammatory cells, via their release
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of multiple cytokines and chemokines, can contribute to the
remodeling process, and interleukin-1 (IL-1), interleukin-4
(IL-4), interleukin-5 (IL-5), interleukin-6 (IL-6), interleukin-
10 (IL-10), interleukin-13 (IL-13), transforming growth
factor-b (TGF-b), and interferon-g (IFN-g) have been cor-
related with the development of pulmonary hypertension
(PH).6–8 Although several mechanisms of cellular immune-
mediated vascular injury are conceivable,6–10 the pathogenic
signiﬁcance of inﬁltrating cells in Sistosome granuloma is
still poorly understood, which is the subject of this short
communication.
Thus, knowledge about the mechanisms of regulation of
these inﬂammatory mediators may help in elucidating the
physiological consequences and to build the model for pul-
monary vascular remodeling. A ﬁrst step toward this goal is
to map the most active cellular components in the granu-
loma that may contribute to secretion of inﬂammatory
mediators. In this report, we evaluated the number and
cross-sectional distribution of inﬂammatory cells viz. mast
cell, CD3þ, CD14þ, CD15þ, and CD68þ in 8, 12, and 14




We have two groups with diﬀerent methods of infection and
duration between infection and sacriﬁce. The female mice
(aged 5–6 weeks) of group I and group II were bred and
housed under speciﬁc pathogen-free conditions. The proto-
cols and surgical procedures were approved by the local
ethical committees of the Natural History Museum,
London, UK; the University of Kent, UK; and the
University of Colorado, Denver, USA. The details of
groups I and II are discussed below.
Group I (prepared in the Natural History Museum,
London, UK and the University of Kent, UK): A Belo
Horizonte strain of S. mansoni was used in all experiments.
Female standard outbred BKW adult mice were infected
with a suspension containing 100 cercariae (maintained at
the Natural History Museum, London, UK). Brieﬂy, mice
were paddled in the warm snail water for approximately
30min. At the end of the infection period, the mice were
transferred back into their cages. The cercariae matured
into worms and laid eggs at the 5th week of infection.
Most pathology in schistosome-infected animals was max-
imal by the 8th week of infection. The animals were sacriﬁced
after 8 (n¼ 10) and 12 (n¼ 10) weeks post infection, includ-
ing the control non-infected mice (n¼ 5). Group I pointed
out the qualitative and quantitative histopathological
aspects of granulomas following natural infection via cercar-
iae only. We used a unique BKW strain and these animals
developed schistosoma in a more natural way as this occurs
in humans. The morphometric analysis of the granulomas
and pulmonary vessels are explained in Kolosionek et al.5
Group II (prepared in the University of Colorado,
Denver, USA), S. mansoni (infected n¼ 4), control (non-
infected mice, n¼ 2): The mice were given a dose of 35
cercariae/mouse (NMRI strain) by restraining the mice
with their tail in a vial of water containing the cercariae
for 30min. The mice were then euthanized after 99 days
(14 weeks) post-infection with S. mansoni. The lung and
liver paraﬃn blocks were sent from the School of Medicine,
University of Colorado, Denver to the University of Kent.
For increasing the strength of the study the non-infected
controls of the two groups, i.e. groups I and II, were clubbed
(n¼ 7) and used as one control group for comparison
throughout the study. For further details on animal treat-
ment, tissue preparation and protocols for groups I and II,
please see the references.5,7
Tissue preparation
Lung and liver: The right lung lobe and liver were washed
with saline followed by 4% formaldehyde infusion into the
trachea. Next, lungs were removed and placed in 4% for-
maldehyde for 24 h. After this time, they were placed in
1PBS for 24 h, followed by dehydration and paraﬃn
embedding (Tissue processor ASP200; Leica, Heidelberg,
Germany). The specimens were stained with hematoxylin
& eosin (H&E) according to standard protocols to assess
the integrity of tissues. The left lung was washed with
saline and frozen at 80C for future investigations.
Mast cell histochemical staining
Toluidine blue staining was used to detect mast cells, as
previously described.9 After deparaﬃnization, the sections
were soaked for 2–3min in a solution of 1% toluidine blue,
pH 2.2 (Sigma, Munich, Germany). The staining solution
was then drained oﬀ and sections were dehydrated in 96–
100% ethanol for 20–30 s, dipped in xylene, and cover-
slipped carefully.
Immunohistochemistry and quantification
Formalin-ﬁxed paraﬃn-embedded blocks of lung tissue
infected with S. mansoni and non-infected healthy lungs
were mounted on positively charged glass slides (R.
Langenbrinck, Teningen, Germany). From each tissue
block, sections of 3-mm thickness were obtained and immu-
nohistochemistry was performed. The lung tissue sections
were deparaﬃnized in xylol and re-hydrated in a graded etha-
nol series. Antigen retrieval was performed by pressure cook-
ing in Rodent Decloaker (Biocare Medical) for 20min
following blocking with bovine serum albumin (10%) for
1 h. Primary antibodies against the following proteins were
used: (1) CD3þ cells: CD3 (1:200; BiocareMedical, Pike Lane
Concord, CA, USA); (2) CD14þ cells: CD14 (1:20; Zytomed,
Berlin, Germany); (3) CD15þ cells: CD15 (1:10; Santa Cruz,
Dallas, TX, USA); (4) CD68þ cells: CD68 (1:50;
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Novus Biologicals, Southpark Way, Littleton, CO, USA);
and incubation with each antibody was carried out overnight
at 4C. Development of the signals was achieved by alkaline
phosphatase method andWarp red chromogen kit (Biocare),
followed by the counterstain with H&E. The slides were de-
hydrated in absolute ethanol and xylol and cover-slipped
using mounting medium. For positive controls, mouse
spleen was used. Speciﬁcity of antibodies was demonstrated
in negative control sections of the lung tissue (primary anti-
body absent). Every ﬁfth section was selected, labeled, and
stained. Images were captured by Leica DFC290 HD digital
camera (Leica) and transferred to a computer containing
software for image analysis. The sections were examined
under a Leica DM 2500 microscope using Leica QWin ima-
ging software (Leica).
Cell counting
The positively stained cells were counted in whole tissue
sections by light microscopy (Leica Instruments, Nussloch,
Germany) using ImageJ software (National Institutes of
Health, Bethesda, MD, USA). Inﬂammatory cell counts
were quantiﬁed as total number of cells per mm2 tissue.
All experiments were performed in a coded format, with
the investigators lacking knowledge of the speciﬁc experi-
mental group identiﬁers before ﬁnal data reporting.
Microscopic evaluation was carried out in a timely
manner without any reduction in the color intensity. The
coeﬃcient of variation for repeat cell counts for the same
observer for each antibody was <5%. We also conﬁrmed
that inter-observer coeﬃcients of variation were <10% for
all antibodies used in the study.
Statistical analysis
Data are presented as the mean standard error of the
mean (SEM). Graphical and statistical analyses were
performed with GraphPadPrism5 (GraphPad, San Diego,
CA, USA). Statistical comparisons between two groups
were performed using paired and unpaired Student’s
t-tests with Welch correction, where appropriate, with a
probability value of P< 0.05 considered to be statistically
signiﬁcant.
Results
As mentioned previously, pulmonary vascular remodeling
correlates with the local presence of granulomas, with remo-
deled pulmonary vessels, were seen in 46% of the lungs in
close proximity to the granuloma.5 These ﬁndings encour-
aged us to trace the actual source of inﬂammation; there-
fore, we mapped the cells of immune system in the same
animal model used in Kolosionek et al.5 Table 1 represents
the analysis of immune cells in Schistosoma-infected and
non-infected healthy controls.
Mast cells profile
There was a progressive increase in the number of mast cells,
in particular in the area adjacent to the granulomas in the
lung and liver (Fig. 1a–g). The increase was seen as early as
eight weeks (group I) (0.054 0.02 versus 0.0 0.0 cells/
mm2 in the controls, respectively; P¼ 0.035) and 12 weeks
(group I) (0.17 0.06 versus 0.0 0.0 cells/mm2 in the con-
trols, respectively; P¼ 0.014). A similar pattern was noticed
in group II at 14 weeks (0.19 0.04 versus 0.0 0.0 cells/
mm2 in the controls, respectively; P¼ 0.015) (Fig. 1a). The
pattern in the lung is similar to the mast cells that are adja-
cent to the granulomas in the liver cells of the same animals
(Fig. 1b). Quantiﬁcation of mast cells revealed a signiﬁcant
diﬀerence in the distribution in group I at 12 weeks
(0.37 0.10 compared to 0.0081 0.008 cells/mm2, in the
controls; respectively; P¼ 0.012) and in group II at 14
weeks (0.46 0.10 compared to 0.0081 0.008 cells/mm2
Table 1. Distribution of inflammatory cells in 8, 12, and 14 weeks’ post-infection with Schistosoma mansoni.
Immune cell count
Immune cells Tissue Control 8 weeks 12 weeks 14 weeks Figures
Mast cells Lung 0.0 0.0 0.054 0.02* 0.17 0.06* 0.19 0.04* 1a
Liver 0.0081 0.008 0.37 0.10* 0.46 0.10* 1b
CD3þ Lung 12.60 1.36 29.59 3.2* 35.0 3.92* 16.50 1.09* 2a
Liver 12.77 4.01 107.8 3.6* 112.6 24.75* 2b
CD14þ Lung 3.24 0.85 8.42 1.22* 14.99 3.17* 13.89 1.39* 3a
Liver 4.77 0.40 12.39 1.62* 12.75 2.17* 3b
CD68þ Lung 0.76 0.46 3.48 1.72 21.70 6.6* 6.21 0.69* 4a
Liver 4.37 0.47 12.26 1.89* 8.73 1.73 4b
CD15þ Lung 1.61 0.44 9.30 1.67* 15.95 3.90* 13.30 2.45* 5a
Liver 4.68 1.08 107.4 8.98* 45.01 2.80* 5b
Data are presented as the mean standard error of the mean (SEM). Statistical comparisons between two groups were performed using paired and unpaired
Student’s t-tests with Welch correction, where appropriate, with a probability value of P< 0.05 (*) considered to be statistically significant.
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in the control, respectively; P¼ 0.01) (Fig. 1b). The majority
of mast cells were de-granulated (increased size and less
granule staining) and were mainly seen either inside or in
close proximity to granuloma (Fig. 1d and 1f).
CD3þ cells: The total number of CD3þ cells in the lung
and liver was signiﬁcantly higher compared to control
(Fig. 2a–i). This increase was seen at the early stage of
eight weeks (29.59 3.2) and at week 12 (35.0 3.92) com-
pared to the controls (12.60 1.36 cells/mm2, P 0.0001,
each) (Fig. 2a). The same pattern was noticed in group II
and at 14 weeks (16.50 1.09 compared to 12.60 1.36
cells/mm2 of the control, P¼ 0.045) (Fig. 2a). It was also
noticed that CD3þ cells were signiﬁcantly increased in both
groups in the liver (group 1, 12 weeks 107.8 3.6 versus
12.77 4.01 cells/mm2 of the control, P 0.0001) and in
group II (112.6 24.75 versus 12.77 4.01 cells/mm2 of
the control, P¼ 0.028) (Fig. 2b). The acute stage granuloma
was characterized by dense accretion of CD3þ lymphocytes
as can be witnessed from Fig. 2d and 2g.
CD14þ cells: As can be seen from the respective immu-
nostaining and quantiﬁcation, the CD14þ cells in the lung
and liver were signiﬁcantly higher compared to the control
(Fig. 3a–i). This increase was seen at the early stage of eight
weeks (8.42 1.22) and at week 12 (14.99 3.17 compared
to the controls 3.24 0.85 cells/mm2, P¼ 0.001; each)
(Fig. 3a). The same pattern was noticed in group II at 14
weeks (13.89 1.39 compared to 3.24 0.85 cells/mm2 of
the control, P¼ 0.0013) (Fig. 3a). It was also noticed that
CD14þ cells were signiﬁcantly increased in both groups in
the liver (group 1, 12 weeks 12.39 1.62 versus 4.77 0.40
cells/mm2 of the control, P¼ 0.003) and in group II
(12.75 2.17 versus 4.77 0.40 cells/mm2 of the control,
P¼ 0.036) (Fig. 3b). The CD14þ cells were excessively pre-
sent in infected liver, especially inside and near the bound-
ary of granuloma when compared to control livers (Fig. 3g
and 3h).
CD68þ cells: The total number of CD68þ cells in the lung
and liver was signiﬁcantly higher compared to the control
(Fig. 4a–i). This increase was seen at week 12 (21.70 6.6
compared to the controls 0.76 0.46 cells/mm2, P¼ 0.005)
(Fig. 4a). The same pattern was noticed in group II at 14
weeks (6.21 0.69 compared to 0.76 0.46 cells/mm2 of the
Fig. 1. Quantification and staining of mast cells in Schistosoma-infected and non-infected healthy controls. (a) Quantification of mast cells from
control, group I (8-week and 12-week infection) and group II (14-week infection) in the lungs; and (b) from control, group I (12-week infection)
and group II (14-week infection) in the liver. (c–g) Paraffin tissue sections were stained with toluidine blue to detect mast cells. Shown are
representative micrographs of (c) positive control (rat lung, with induced Monocrotaline, 5); (d) Schistosoma-infected lung, 40; (e) non-infected
healthy control lung, 5; (f) Schistosoma-infected liver sections, 5; and (g) non-infected healthy control liver, 5. Arrowheads indicate the
positively stained cells (purple); scale bar¼ 20 mm.
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controls, P¼ 0.0012) (Fig. 4a). CD68þ cells were also
noticed to signiﬁcantly increase in group I in the liver (12
weeks, 12.26 1.89 versus 4.37 0.47 cells/mm2 of the con-
trols, P¼ 0.0068) (Fig. 4b).
CD15þ cells: The total number of CD15þ cells in the lung
and liver was signiﬁcantly higher compared to the control
(Fig. 5a–i). This increase was seen at the early stage of eight
weeks (9.30 1.67) and at week 12 (15.95 3.90 compared
to the controls 1.61 0.44 cells/mm2, P¼ 0.0002;
P¼ 0.0013, respectively) (Fig. 5a). The same pattern was
noticed in group II at 14 weeks (13.30 2.45 compared to
1.61 0.44 cells/mm2of the control, P¼ 0.009) (Fig. 5a).
CD15þ cells were also noticed to signiﬁcantly increase in
both groups in the liver (group 1, 12 weeks 107.4 8.98
versus 4.68 1.08 cells/mm2 of the control, P 0.0001)
and in group II (45.01 2.80 versus 4.68 1.08 cells/mm2
of the control, P¼ 0.0055) (Fig. 5b).
Discussion
The Schistosoma egg antigens result in all the changes in the
pulmonary vasculature by eliciting an immune response
with granuloma formation. The granulomatous web recruits
a variety of inﬂammatory cells and initiates an intricate cas-
cade by involving inﬂammatory mediators such as mast
cells, macrophages, dendritic cells, lymphocytes, monocytes,
and neutrophils.1–5 The understanding of inﬂammatory cell
behavior at diﬀerent stages of the immunological reaction
will contribute to the understanding of the vascular path-
ology of schistosomiasis. The presence, involvement, and
expression of each of these cells in granuloma construc-
tion are still not clear, and thus it becomes obligatory to
dissect the complexity of granuloma. Based on this concept,
this study identiﬁed crucial inﬂammatory mediators
and provided some details on the role of mast cells, T
cells, monocytes, macrophages, and neutrophils in
schistosomiasis.
We noticed a signiﬁcant progressive increase in the
number of mast cells post week 8 of infection in the lung
and liver when compared to uninfected healthy controls.
Previous reports showed that the perivascular mast cells
were increased in various pulmonary hypertension models
and the majority of them were degranulated (activated) in
the lungs of patients.9,10 In these models, mast cells have a
key role in the activation of matrix metalloproteinase-2 and
9,11 which have been also recognized in the process of
inﬂammation and tissue remodeling by Schermuly et al.12
Thus, our ﬁndings conﬁrm a similar increase of mast cells
suggesting that these cells may contribute to pulmonary vas-
cular remodeling.
Fig. 2. Quantification and immunostaining of CD3þ T cells in Schistosoma-infected and non-infected healthy controls in groups I and II.
(a) Quantification of CD3þ T cells from control, group I (8-week and 12-week infection) and group II (14-week infection) in the lungs; and
(b) from control, group I (12-week infection) and group II (14-week infection) in the liver. (c–i) Paraffin lung tissue sections of (c) positive control
mouse spleen, 5; (d) Schistosoma-infected lung, 20; (e) non-infected healthy control lung, 5; (f) negative control lung (CD3 antibody absent),
5; (g) Schistosoma-infected liver, 5; (h) non-infected healthy control liver, 5; and (i) negative control liver (CD3 antibody absent), 5. The
tissue section cells were stained with anti-CD3 to detect T cells. Arrowheads indicate the positively stained cells (red), scale bar¼ 20mm.
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T cells have been implicated in several immune-patholo-
gical events during helminthic infection including schisto-
somiasis.13,14 These cells may play a vital role in
pulmonary vascular remodeling as they provide immuno-
logical aid for leukocytes through cytokines secretion.15,16
The T lymphocytes undergo extensive changes in their
immunological proﬁle during the infection process from
Th1, Th2, and Th17 and express a plethora of cytokines
like interferon-g, tumor necrosis factor (TNF)-a, IL-2 (Th-
1 type) and later release IL-4, IL-10, and IL-13 (Th-2 type)
which have been correlated well in pulmonary vascular dis-
eases.13,15,16 Thus, one can assume that T cells and T cell-
derived cytokines can regulate the immunological response
in the body and are central in the development of patho-
logical conditions.13,17
In this study, we noticed a signiﬁcant increase in the
number of CD3þ cells during the acute phase of infection
in the lung and liver compared to respective controls. The
recruitment and migration of CD3þ lymphocytes to the
granuloma peaked during 8–12 weeks and the respective
immunostainings revealed CD3þ cells constituted a major
portion of granuloma. Furthermore, the granuloma located
around eggs in the liver revealed greater expression of CD3þ
cells per mm2 of area compared to those in lung. Mauad
et al. also recently reported an increase in the density of
CD3þ T cells and mast cells in the lungs of patients that
died of schistosomiasis-associated PAH.18
As explained above, the Schistosoma egg-induced granu-
loma is also dependent on the mobilization of macrophages
and monocytes; thus, increased expression of these inﬂam-
matory cells has been reported recently.3,7 The stimulated
macrophages may present antigens to T cells leading to T
cell activation and induce the release of IL-1b, IL-6, TNF-a,
and IL-10, facilitating the inﬂammation and remodel-
ing.13,15,19 Tissue remodeling and ﬁbrotic responses in
chronic inﬂammatory conditions have been associated
with activation of macrophages. The impaired production
of monocyte chemoattractant protein-1, TNF-a, and inter-
feron-g may encourage monocyte migration into granu-
lomas and diﬀerentiation of monocytes into macrophages,
as well as macrophage activation within the granulomas.8,13
In histological studies, the mononuclear cell inﬂammatory
inﬁltrate observed around remodeled vessels, including
plexiform lesions and the cells involved, are of monocytes/
macrophage lineage.19,20 Savai et al. recently reported
increased perivascular monocytes (CD14þ) and
Fig. 3. Quantification and immunostaining of CD14þ cells in Schistosoma-infected and non-infected healthy controls in groups I and II.
(a) Quantification of CD14þ cells from control, group I (8-week and 12-week infection) and group II (14-week infection) in the lungs; and (b) from
control, group I (12-week infection) and group II (14-week infection) in the liver. (c–i) Paraffin lung tissue sections of (c) positive control mouse
spleen, 5; (d) Schistosoma-infected lung, 20; (e) non-infected healthy control lung, 5; (f) negative control lung (CD14 antibody absent), 5;
(g) Schistosoma-infected liver, 5; (h) non-infected healthy control liver, 5; and (i) negative control liver (CD14 antibody absent), 5. The tissue
section cells were stained with anti-CD14 to detect positively stained cells. Arrowheads indicate the positively stained cells (red),
scale bar¼ 20mm.
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macrophages (CD68þ) in human idiopathic PAH.15 In the
present study, the granulomas observed in the lung and liver
also consisted of monocyte and macrophage inﬁltration spe-
ciﬁcally at 12 weeks of infection.
Furthermore, neutrophils are generally among the ﬁrst
cells to be recruited to the site of inﬂammation, where
they kill invading pathogens through phagocytosis and
enzymatic digestion.21 Precisely, they penetrate between
the endothelial cells with the help of cell adhesion molecules
(CAMs) and collect in the inﬂammatory exudates.21 They
produce a range of cytokines due to a variety of receptors on
their surface such as TNF-a, IL-1, IL-8, TGF-b, and MIP.
All of these modulate the immune response and leads to
pulmonary vascular remodeling.13 This may suggest that
neutrophils in the granuloma can contribute to the remodel-
ing. Our results showed a signiﬁcant increase in the CD15þ
cells after eight weeks of infection in lungs and liver. Of
note, the number of CD15þcells were greater in the liver
than the lungs per mm2 of area and these were more
expressed inside and in close proximity to granuloma. It
was recently shown that in response to the CD15 antigens,
a large amount of IL-10 was secreted in vitro; IL-10 can
suppress Th1 responses in animals, which may partly con-
tribute to the Th2 dominance in early stages of
schistosomiasis. The presence of anti- CD15 antibodies in
S. haematobium and S. japonicum infected individuals raises
the probability for an autoimmune disorder during infec-
tions by all human Schistosoma species.22
As we learn more about the complexity of the human
immune response to infection, it is becoming increasingly
important to ﬁnd meaningful ways of identifying and
interpreting patterns of these responses. This study high-
lighted the importance of assaying a greater range of
inﬂammatory cells and their contribution in Schistosoma
infection. This integrated approach provides a powerful
means of relating the immune phenotype elicited by para-
site antigens and an eﬀective means of assessing the
immunological impact of experimental infection on
immune-mediated disease. The above changes in the
inﬂammatory cells and their contribution in modulating
the level of inﬂammatory mediators conﬁrm our original
hypothesis3,6–8 of the importance of these mediators in the
remodeling process.
This paper is ﬁrst to systematically characterize the qual-
ity and quantity of diﬀerent inﬂammatory/immune cells
showing dynamic changes in schistosomiasis pulmonary
vascular responses. Our ﬁndings not only revealed detailed
characterization of the inﬂammatory cells in
Fig. 4. Quantification and immunostaining of CD68þ cells in Schistosoma-infected and non-infected healthy controls in groups I and II.
(a) Quantification of CD68þ cells from control, group I (8-week and 12-week infection) and group II (14-week infection) in the lungs; and (b) from
control, group I (12-week infection) and group II (14-week infection) in the liver. (c–i) Paraffin lung tissue sections of (c) positive control mouse
spleen, 5; (d) Schistosoma-infected lung, 20; (e) non-infected healthy control lung, 5; (f) negative control lung (CD68 antibody absent), 5;
(g) Schistosoma-infected liver, 5; (h) non-infected healthy control liver, 5; and (i) negative control liver (CD68 antibody absent), 5. The tissue
section cells were stained with anti-CD68 to detect positively stained cells. Arrowheads indicate the positively stained cells (red), scale
bar¼ 20mm.
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schistosomiasis, but also suggest that these cells may be
potential therapeutic targets for the control of
inﬂammation.
Among the limitations, our data revealed enhanced traf-
ﬁcking and inﬁltration of several types of immune cells in
the lungs and liver following infection at diﬀerent doses and
time points in the mouse model and not in humans.
Demonstrating a similar enhancement of the inﬂammatory
cells discussed here in lung and/or liver tissues from humans
with schistosomiasis would reinforce the translational
importance of the ﬁndings, which will be our subsequent
study. Also, more cells such as CD4þ T cells, CD8þ T
cells, CD209þ dendrite cells, CD45þ leucocytes, CCL5/
RANTESþ, CD161þ NK cells, etc., have to be mapped
and more comprehensive micro-mapping of granuloma in
relation to Schistosoma egg are important for future studies.
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